Amedeo Smart

Free Medical Literature Service

 

Amedeo

Schizophrenia
  Free Subscription

Articles published in
Br J Psychiatry
    March 2026
  1. WU X, Lu C, Kong H, Chen R, et al
    Recalibrating the epigenetic clock reveals divergent DNA methylation age signatures across schizophrenia, bipolar disorder and major depressive disorder.
    Br J Psychiatry. 2026 Mar 25:1-9. doi: 10.1192/bjp.2025.10508.
    >> Share

  2. JULIA L, Ortiz-Garcia de la Foz V, Gonzalez-Segura A, Alemany M, et al
    Predicting early clinical recovery in first-episode psychosis: development and external validation of a clinically interpretable multivariable model.
    Br J Psychiatry. 2026 Mar 23:1-12. doi: 10.1192/bjp.2026.10581.
    >> Share

  3. LEIGHTON SP, Leong IL, Machlanski D, Perry BI, et al
    Antipsychotic-induced weight gain in psychosis: causal mediation analysis and feasibility study of causal actionable prediction model development using counterfactuals to target obesity.
    Br J Psychiatry. 2026 Mar 9:1-10. doi: 10.1192/bjp.2026.10561.
    >> Share

  4. OLIVER D, Fusar-Poli P
    Can critical components of effective early intervention in psychosis also advance early detection and preventive care for young people at risk?
    Br J Psychiatry. 2026 Mar 9:1-3. doi: 10.1192/bjp.2026.10593.
    >> Share

    February 2026
  5. KUMARI V, Otermans PCJ
    Chatbot psychosis: moving beyond recognition to mechanistic understanding and harm reduction.
    Br J Psychiatry. 2026 Feb 9:1-3. doi: 10.1192/bjp.2026.10541.
    >> Share

  6. KARA VM
    Cultural heritage tourism as an adjunct in schizophrenia.
    Br J Psychiatry. 2026 Feb 5:1-2. doi: 10.1192/bjp.2025.10532.
    >> Share

    January 2026
  7. CORBEIL O, Montalvo I, Labad J, Luykx JJ, et al
    Real-world studies in psychiatry: insights into antipsychotic-associated breast cancer risk and their broader implications.
    Br J Psychiatry. 2026;228:7-9.
    >> Share

    December 2025
  8. FERNANDEZ-EGEA E
    Clozapine clinics at the crossroads and the opportunity to redesign services for people with chronic schizophrenia.
    Br J Psychiatry. 2025 Dec 18:1-2. doi: 10.1192/bjp.2025.10513.
    >> Share

  9. ALEMAN-MORILLO C, Garcia-San-Martin N, Bethlehem RAI, Dorfschmidt L, et al
    Medication and atypical brain maturation in psychosis associated with long-term cognitive decline and symptom progression.
    Br J Psychiatry. 2025 Dec 11:1-11. doi: 10.1192/bjp.2025.10482.
    >> Share

    November 2025
  10. AFE T, Ogunsemi O
    Revisiting Lambo's pioneering work: the role of cultural factors in paranoid psychosis among the Yoruba tribe - 70-year old perspective: commentary, Afe and Ogunsemi.
    Br J Psychiatry. 2025 Nov 24:1-2. doi: 10.1192/bjp.2025.10487.
    >> Share

  11. DIEDERICH F, Oloyede E, Taylor D, Bachmann CJ, et al
    Economic evaluation of different haematological monitoring schemes for patients with treatment-resistant schizophrenia using clozapine.
    Br J Psychiatry. 2025 Nov 13:1-8. doi: 10.1192/bjp.2025.10424.
    >> Share

  12. HOWES O, Kapi M, Bukala BR
    Does relapse matter? Insights from new data in schizophrenia.
    Br J Psychiatry. 2025 Nov 10:1-3. doi: 10.1192/bjp.2025.10470.
    >> Share

    October 2025
  13. LIU W, Wang C, Guo F, Guo M, et al
    Structural connectivity of striatal subregions in first-episode schizophrenia: links to positive symptoms and treatment response.
    Br J Psychiatry. 2025 Oct 24:1-8. doi: 10.1192/bjp.2025.10434.
    >> Share

  14. PEI H, Jiang S, Hou C, Li H, et al
    Accelerated ageing unfolds along the sensorimotor-association cortical axis in schizophrenia: multi-site study.
    Br J Psychiatry. 2025 Oct 1:1-9. doi: 10.1192/bjp.2025.10364.
    >> Share

    September 2025
  15. PATEL R
    Cannabis and psychosis: minimising harm while maximising therapeutic potential.
    Br J Psychiatry. 2025 Sep 11:1-2. doi: 10.1192/bjp.2025.10389.
    >> Share

  16. MONCRIEFF J, Priebe S
    The association between relapse and the outcome of schizophrenia and recurrent psychotic disorders: commentary, Moncrieff et al.
    Br J Psychiatry. 2025 Sep 8:1-2. doi: 10.1192/bjp.2025.
    >> Share

  17. WILKINSON H, Johns LC, Batchelor R, Lau-Zhu A, et al
    Cognitive behavioural therapy for sleep problems in psychosis: systematic review of effectiveness and acceptability - CORRIGENDUM.
    Br J Psychiatry. 2025 Sep 4:1. doi: 10.1192/bjp.2025.10420.
    >> Share

  18. PRIES LK, Prachason T, Arias-Magnasco A, Lin BD, et al
    Impact of puberty timing, status and oestradiol on psychotic experiences in the context of exposomic and genomic vulnerability to schizophrenia in female adolescents: longitudinal ABCD study.
    Br J Psychiatry. 2025 Sep 3:1-8. doi: 10.1192/bjp.2025.
    >> Share

    August 2025
  19. DE PERI L, Mellacqua ZB
    The association between relapse and the outcome of schizophrenia and recurrent psychotic disorders: commentary, De Peri et al.
    Br J Psychiatry. 2025 Aug 19:1. doi: 10.1192/bjp.2025.10370.
    >> Share

    July 2025
  20. KISELY S, Bull C, Newton-Howes G, Zirnsak T, et al
    Restricting community treatment orders to people with non-affective psychosis is needed to reduce use and improve subsequent outcomes: Queensland-wide cohort study.
    Br J Psychiatry. 2025 Jul 23:1-6. doi: 10.1192/bjp.2025.10317.
    >> Share

  21. HASHIMOTO K
    Host microbiota in clozapine-induced ileus and pneumonia among people with schizophrenia.
    Br J Psychiatry. 2025 Jul 22:1-2. doi: 10.1192/bjp.2024.
    >> Share

  22. TREW A, Rodda J, Shergill SS
    The association between relapse and the outcome of schizophrenia and recurrent psychotic disorders.
    Br J Psychiatry. 2025 Jul 21:1-2. doi: 10.1192/bjp.2025.
    >> Share

  23. ZHOU H, Luo H, Tang JY, Honer WG, et al
    Population-based study of long-term mortality risk associated with clozapine use among patients with schizophrenia.
    Br J Psychiatry. 2025 Jul 4:1-9. doi: 10.1192/bjp.2025.10312.
    >> Share

    June 2025
  24. WILLIAMS R, Penington E, Gupta V, Quirk A, et al
    Critical components of 'Early Intervention in Psychosis': national retrospective cohort study.
    Br J Psychiatry. 2025 Jun 26:1-9. doi: 10.1192/bjp.2025.
    >> Share

  25. REILLY TJ, Chesney E, Al-Diwani A, Jewell A, et al
    Identification of menstrual psychosis cases using electronic health records.
    Br J Psychiatry. 2025 Jun 23:1-3. doi: 10.1192/bjp.2025.
    >> Share

  26. ANDREU-BERNABEU A, Gonzalez-Penas J, Mora A, Bernardo M, et al
    Linking prolonged childhood and adolescent loneliness to schizophrenia spectrum disorders: results from EU-GEI study.
    Br J Psychiatry. 2025 Jun 16:1-9. doi: 10.1192/bjp.2025.
    >> Share

  27. MUNOZ-CARACUEL M, Aleman-Morillo C, Garcia-San-Martin N, Garrido-Torres N, et al
    Predicting clinical and functional trajectories in individuals with first-episode psychosis by baseline deviations in grey matter volume.
    Br J Psychiatry. 2025 Jun 16:1-9. doi: 10.1192/bjp.2025.
    >> Share

  28. WETZLER SR, Madora MJ
    Puerperal insanity: history of postpartum psychosis.
    Br J Psychiatry. 2025;226:426-427.
    >> Share

    May 2025
  29. WILKINSON H, Johns LC, Batchelor R, Lau-Zhu A, et al
    Cognitive behavioural therapy for sleep problems in psychosis: systematic review of effectiveness and acceptability.
    Br J Psychiatry. 2025 May 22:1-16. doi: 10.1192/bjp.2025.
    >> Share

  30. O'HARE K, Lang U, Healy C, Kougianou I, et al
    Psychosis and bipolar disorder risk in child and adolescent mental health services in the UK: population cohort study.
    Br J Psychiatry. 2025 May 14:1-7. doi: 10.1192/bjp.2025.
    >> Share

  31. MUSTONEN A, Taipale H, Denissoff A, Ellila V, et al
    Real-world effectiveness of antipsychotic medication in relapse prevention after cannabis-induced psychosis.
    Br J Psychiatry. 2025 May 6:1-7. doi: 10.1192/bjp.2025.
    >> Share

  32. SHAJU A, Mishra A, Mohapatra D, Srinivasan A, et al
    Efficacy and safety of cholinergic modulators in patients with schizophrenia: meta-analysis of randomised controlled trials.
    Br J Psychiatry. 2025 May 2:1-11. doi: 10.1192/bjp.2025.
    >> Share

    April 2025
  33. MONCRIEFF J, Pillai E, Marston L, Lewis G, et al
    The association between relapse and the outcome of schizophrenia and recurrent psychotic disorders.
    Br J Psychiatry. 2025 Apr 14:1-7. doi: 10.1192/bjp.2024.
    >> Share

  34. LYMAN M, Fanshawe JB, Brewin J, Fanshawe TR, et al
    Introduction of point-of-care blood testing in early intervention in psychosis services: effects on physical health screening.
    Br J Psychiatry. 2025 Apr 11:1-6. doi: 10.1192/bjp.2025.
    >> Share

    March 2025
  35. COWMAN M, Hodgekins J, Griffiths SL, Frawley E, et al
    Cognitive and clinical profiles in first-episode psychosis and their relationship with functional outcomes.
    Br J Psychiatry. 2025 Mar 26:1-8. doi: 10.1192/bjp.2025.
    >> Share

  36. WHITING D, Glogowska M, Mallett S, Maughan D, et al
    Use of a violence risk prediction tool (Oxford Mental Illness and Violence) in early intervention in psychosis services: mixed methods study of acceptability, feasibility and clinical role.
    Br J Psychiatry. 2025 Mar 20:1-10. doi: 10.1192/bjp.2024.
    >> Share

    February 2025
  37. LAGERBERG T, Lambe S, Paulino A, Yu R, et al
    Systematic review of risk factors for violence in psychosis: 10-year update.
    Br J Psychiatry. 2025;226:100-107.
    >> Share

  38. ZANCHETA SB, de Alencar Quirino AH, Gomes SP, Nogueira GN, et al
    Adverse childhood experiences and psychological functioning among women with schizophrenia or bipolar disorder: population-based study: commentary, Zancheta et al.
    Br J Psychiatry. 2025;226:114-115.
    >> Share

    January 2025
  39. KANG S, Yang JS, Yun BH, Gelaye B, et al
    Antipsychotic continuation during pregnancy and risk of postpartum relapse in women with schizophrenia: nationwide register-based study.
    Br J Psychiatry. 2025 Jan 10:1-8. doi: 10.1192/bjp.2024.
    >> Share

  40. WANG F, Liu Z, Wang J, Li X, et al
    Aberrant controllability of functional connectome during working memory tasks in patients with schizophrenia and unaffected siblings.
    Br J Psychiatry. 2025 Jan 7:1-10. doi: 10.1192/bjp.2024.
    >> Share

  41. FERNANDEZ-EGEA E, McCutcheon RA
    Clozapine monitoring requirements: is it time for an update?
    Br J Psychiatry. 2025;226:1-3.
    >> Share

    December 2024
  42. ZHOU J, Millier A, Aballea S, Francois C, et al
    Cost-effectiveness of ten commonly used antipsychotics in first-episode schizophrenia in the UK: economic evaluation based on a de novo discrete event simulation model.
    Br J Psychiatry. 2024 Dec 26:1-8. doi: 10.1192/bjp.2024.
    >> Share

  43. SMITH KA, Boyce N, Chevance A, Chiocchia V, et al
    Triangulating evidence from the GALENOS living systematic review on trace amine-associated receptor 1 (TAAR1) agonists in psychosis.
    Br J Psychiatry. 2024 Dec 23:1-9. doi: 10.1192/bjp.2024.
    >> Share

  44. NAUGHTON S, McGinty G, Duffy N, Marshall D, et al
    Intervening early across the lifespan: going beyond youth-focused psychosis care to meet the needs of women.
    Br J Psychiatry. 2024 Dec 4:1-3. doi: 10.1192/bjp.2024.
    >> Share

  45. YANG LH, Grivel MM, Blasco D, Girgis RR, et al
    Parsing stigma's relationship with the psychosocial functioning of youth identified as at clinical high risk for psychosis: evaluating whether symptom stigma or labelling stigma is stronger.
    Br J Psychiatry. 2024 Dec 4:1-9. doi: 10.1192/bjp.2024.
    >> Share

  46. CHESNEY E, Reilly TJ, Scott F, Slimani I, et al
    Psychosis associated with cannabis withdrawal: systematic review and case series.
    Br J Psychiatry. 2024 Dec 3:1-12. doi: 10.1192/bjp.2024.
    >> Share

    November 2024
  47. GREENWOOD K, Jones C, Yaziji N, Healey A, et al
    The Early Youth Engagement (EYE-2) intervention in first-episode psychosis services: pragmatic cluster randomised controlled trial and cost-effectiveness evaluation.
    Br J Psychiatry. 2024 Nov 25:1-9. doi: 10.1192/bjp.2024.
    >> Share

  48. TREUR JL, Thijssen AB, Smit DJA, Tadros R, et al
    Associations of schizophrenia with arrhythmic disorders and electrocardiogram traits: genetic exploration of population samples.
    Br J Psychiatry. 2024 Nov 8:1-9. doi: 10.1192/bjp.2024.
    >> Share

  49. HALL J
    Schizophrenia - new treatments soon.
    Br J Psychiatry. 2024 Nov 8:1-2. doi: 10.1192/bjp.2024.
    >> Share

  50. TESLI N, Vaskinn A
    Violence and schizophrenia: let us take a deep breath and gain a meta-perspective.
    Br J Psychiatry. 2024;225:508-509.
    >> Share

    October 2024
  51. YANG JS, Kang S, Kim K, Tsai AC, et al
    Breast cancer risk among women with schizophrenia and association with duration of antipsychotic use: population-based cohort study in South Korea.
    Br J Psychiatry. 2024 Oct 31:1-7. doi: 10.1192/bjp.2024.
    >> Share

  52. NICHOLLS D, Budd J, Nunn P, French P, et al
    Investigating inequalities in patient outcomes for first-episode psychosis.
    Br J Psychiatry. 2024 Oct 10:1-7. doi: 10.1192/bjp.2024.
    >> Share

    September 2024
  53. JIANG Y, Chang X, Feng J
    Towards a unified theory of the aetiology of schizophrenia.
    Br J Psychiatry. 2024 Sep 23:1-3. doi: 10.1192/bjp.2024.
    >> Share

  54. FERNANDEZ-EGEA E, Flanagan RJ, Taylor D, Gaughran F, et al
    Mortality associated with clozapine: what is the evidence?
    Br J Psychiatry. 2024;225:357-359.
    >> Share

    August 2024
  55. LIU R, Li D, Ma Y, Tang L, et al
    Air pollutants, genetic susceptibility and the risk of schizophrenia: large prospective study.
    Br J Psychiatry. 2024 Aug 9:1-9. doi: 10.1192/bjp.2024.
    >> Share

  56. KIKUCHI Y, Kurosawa M, Sakata M, Takahashi Y, et al
    Effects of titration speed, gender, obesity and concomitant medications on the risk and onset time of clozapine-associated fever among Japanese patients with schizophrenia: retrospective review of charts from 21 hospitals.
    Br J Psychiatry. 2024 Aug 6:1-7. doi: 10.1192/bjp.2024.
    >> Share

  57. FAROOQ S, Hattle M, Kingstone T, Ajnakina O, et al
    Development and initial evaluation of a clinical prediction model for risk of treatment resistance in first-episode psychosis: Schizophrenia Prediction of Resistance to Treatment (SPIRIT).
    Br J Psychiatry. 2024 Aug 5:1-10. doi: 10.1192/bjp.2024.
    >> Share

  58. SHERGILL SS, Meshreky KM
    Towards a unified theory of the aetiology of schizophrenia: commentary, Shergill et al.
    Br J Psychiatry. 2024 Aug 5:1-2. doi: 10.1192/bjp.2024.
    >> Share

  59. KUMARI V
    Towards a unified theory of the aetiology of schizophrenia: commentary, Kumari.
    Br J Psychiatry. 2024;225:341-342.
    >> Share

    July 2024
  60. HUANG ML, Wei LC
    Psychological framework to understand interpersonal violence by forensic patients with psychosis: commentary, Huang & Wei.
    Br J Psychiatry. 2024 Jul 31:1. doi: 10.1192/bjp.2024.
    >> Share

    May 2024
  61. CHEN PH, Tsai SY, Chen PY, Pan CH, et al
    Lipid-modifying agents and risk of all-cause, natural and suicide mortality in schizophrenia: nationwide cohort study.
    Br J Psychiatry. 2024 May 16:1-9. doi: 10.1192/bjp.2024.
    >> Share

  62. FREEMAN D
    Developing psychological treatments for psychosis.
    Br J Psychiatry. 2024;224:147-149.
    >> Share

  63. FERNANDEZ-EGEA E, Chen S, Sanguesa E, Gasso P, et al
    The role of psychosis and clozapine load in excessive checking in treatment-resistant schizophrenia: longitudinal observational study.
    Br J Psychiatry. 2024;224:164-169.
    >> Share

    April 2024
  64. QI R, Qureshi M, Gire N, Chaudhry IB, et al
    Ethnic density and first episode psychosis in the British Pakistani population: findings from the East Lancashire Early Intervention Service.
    Br J Psychiatry. 2024 Apr 18:1-6. doi: 10.1192/bjp.2024.
    >> Share

    March 2024
  65. BONIVENTO C, Kambeitz-Ilankovic L, Maggioni E, Borgwardt S, et al
    Neurocognitive skills and vulnerability for psychosis in depression and across the psychotic spectrum: findings from the PRONIA Consortium - CORRIGENDUM.
    Br J Psychiatry. 2024 Mar 18:1. doi: 10.1192/bjp.2024.
    >> Share

    February 2024
  66. HASSIOTIS A, Noor M, Bebbington P, Ali A, et al
    Borderline intellectual functioning and psychosis: Adult Psychiatric Morbidity Survey evidence - CORRIGENDUM.
    Br J Psychiatry. 2024 Feb 13:1. doi: 10.1192/bjp.2024.
    >> Share

    January 2024
  67. MCCUTCHEON RA, Cannon A, Parmer S, Howes OD, et al
    How to classify antipsychotics: time to ditch dichotomies?
    Br J Psychiatry. 2024;224:20-25.
    >> Share

    November 2023
  68. SAHIN D, Kambeitz-Ilankovic L, Wood S, Dwyer D, et al
    Algorithmic fairness in precision psychiatry: analysis of prediction models in individuals at clinical high risk for psychosis.
    Br J Psychiatry. 2023 Nov 8:1-11. doi: 10.1192/bjp.2023.
    >> Share

    October 2023
  69. LAMBE S, Cooper K, Fazel S, Freeman D, et al
    Psychological framework to understand interpersonal violence by forensic patients with psychosis.
    Br J Psychiatry. 2023 Oct 20:1-8. doi: 10.1192/bjp.2023.
    >> Share

  70. KOHLER-FORSBERG O, Ge F, Hauksdottir A, Thordardottir EB, et al
    Adverse childhood experiences and psychological functioning among women with schizophrenia or bipolar disorder: population-based study.
    Br J Psychiatry. 2023 Oct 18:1-7. doi: 10.1192/bjp.2023.
    >> Share

  71. BONIVENTO C, Kambeitz-Ilankovic L, Maggioni E, Borgwardt S, et al
    Neurocognitive skills and vulnerability for psychosis in depression and across the psychotic spectrum: findings from the PRONIA Consortium.
    Br J Psychiatry. 2023;223:485-492.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016